The efficacy of a topical traditional Chinese medicine formulation Cheong Kun Oil for reducing delayed onset muscle soreness in well trained individuals

The University of Canberra0 个研究点目标入组 45 人开始时间: 2019年6月12日最近更新: 2019年7月15日

试验速览

暂无简介。

•Participants recruited for this study will be:
•1.Males aged between 18-35 years, who are physically active, but naive to eccentric contraction dominated movements.
•2.Free from injuries or conditions that may make it unsafe to exercise (i.e. answers no to everything on the adult pre-exercise screening tool)
•3.Agree to discontinue anti-inflammatory or analgesic medications (oral and topical) 3 days prior to starting the study (NSAIDs, Opioids or Steroids) or any complementary medicines with known anti-inflammatory properties, for example turmeric, glucosamine or high strength fish oils for the duration of the study.
•4.Agree not to introduce any new personal care products such as physiotherapy, OTCs, topical or oral complementary medicine products, skin care, personal hygiene products during the study (due to investigation of adverse effects on skin, skin care and personal hygiene products is prohibited).
•5.Agree to abstain for physical activity for up to 96 hours post eccentric exercise.

•Participants will be excluded if they:
•1.Regularly participate in strength training or long distance running (due to the eccentric contractions associated with these activities).
•2.Allergy to CKPRO or any of its ingredients
•3.Individuals with; broken or infected skin proximal or on the application site; skin affected by diabetes
•4.Individuals who have participated in other clinical trials within 28 days prior starting of the study.
•5.Individuals with medical conditions which anti-inflammatory or analgesic medications must be used.
•6.Individuals who do not meet any of the inclusion criteria.

发起方

The University of Canberra